Document Detail


Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butylbromide.
MedLine Citation:
PMID:  18555031     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyoscine-N-butylbromide (Buscopan, Boehringer Ingelheim) is a widely used antispasmodic in radiological practice. There seems to be no consensus as to best practice within radiology regarding the precautions that need to be taken when prescribing Buscopan. We have performed a thorough review of the available literature and make the following recommendations to those administering Buscopan: (1) enquire whether there is an allergic history; (2) ensure patient literature warns that "in the rare event that following the examination you develop painful, blurred vision in one or both eyes, you must attend hospital immediately for assessment"; (3) warn patients to expect blurred vision and not to drive until this has worn off; (4) remind clinicians that special consideration needs to be given as to the method of investigating patients with cardiac instability, such as those recently admitted with acute coronary syndrome, recurrent cardiac pain at rest, uncontrolled left ventricular failure and recent ventricular arrhythmias.
Authors:
R Dyde; A H Chapman; R Gale; A Mackintosh; D J M Tolan
Publication Detail:
Type:  Journal Article; Review     Date:  2008-05-02
Journal Detail:
Title:  Clinical radiology     Volume:  63     ISSN:  0009-9260     ISO Abbreviation:  Clin Radiol     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-06-16     Completed Date:  2008-09-24     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1306016     Medline TA:  Clin Radiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  739-43     Citation Subset:  IM    
Affiliation:
Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Butylscopolammonium Bromide / contraindications*,  diagnostic use
Cardiovascular Diseases / complications
Glaucoma / complications
Humans
Male
Myasthenia Gravis / complications
Parasympatholytics / contraindications*,  diagnostic use
Porphyrias / complications
Practice Guidelines as Topic
Prostatism / complications
Radiology / methods
Vision, Ocular / drug effects
Visual Acuity / drug effects
Chemical
Reg. No./Substance:
0/Parasympatholytics; 149-64-4/Butylscopolammonium Bromide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin plantari...
Next Document:  Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: corre...